COLUMBUS, Ohio – Michael A. Caligiuri
, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute, will discuss the future of cancer research during a “fireside chat” from 6-8 p.m. Jan. 19 at the Fawcett Center, 2400 Olentangy River Road, in Columbus.
Caligiuri will also talk about cancer prevention and treatment, as well as new cancer therapies and discoveries that are being made at Ohio State. He will discuss how researchers, pharmacists and other healthcare professionals are working together to find a cure for cancer. Those who attend the chat will also hear from cancer patients who have participated in clinical trials.
Caligiuri’s chat is hosted by JamesCare
, which provides support for cancer patients, family and friends through their journey. For more information or to register, call 614-293-6428 or visit cancer.osu.edu/go/support
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute
(NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.
for a high quality photo of Dr. Michael Caligiuri.